| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 50% | 10/20 |
| Female | 50% | 10/20 |
| Indifferent | 0% | 0/20 |
| Unknown | 0% | 0/20 |
| General | ||
| Birth Length | 0% | 0/19 |
| Birth Weight | 0% | 0/19 |
| 10.5% | 2/19 | |
| 10.5% | 2/19 | |
| 10.5% | 2/19 | |
| 47.4% | 9/19 | |
| 73.7% | 14/19 | |
| 89.5% | 17/19 | |
| 100% | 19/19 | |
| 100% | 19/19 | |
| Neurology | ||
| 89.5% | 17/19 | |
| 78.9% | 15/19 | |
| 26.3% | 5/19 | |
| Facial abnormalities | ||
| 5.3% | 1/19 | |
| 36.8% | 7/19 | |
| Abnormality of the nose | 0% | 0/19 |
| 26.3% | 5/19 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/19 |
| 26.3% | 5/19 | |
| Heart | ||
| 10.5% | 2/19 | |
| Gastrointestinal | ||
| 47.4% | 9/19 | |
| Urogenital | ||
| 5.3% | 1/19 | |
| Skeleton | ||
| 52.6% | 10/19 | |
| Skin / Hair / Nails | ||
| 36.8% | 7/19 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/19 |
| 5.3% | 1/19 | |
| Immune | 0% | 0/19 |
| Neoplasia | ||
| Neoplasia | 0% | 0/19 |
| Inheritance | ||
| 100% | 18/18 | |
IQSEC2